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Neisseria gonorrhoeae utilizes the mtrCDE-encoded efflux pump system to resist not only host-derived,
hydrophobic antimicrobials that bathe mucosal surfaces, which likely aids in its ability to colonize and infect
numerous sites within the human host, but also antibiotics that have been used clinically to treat infections.
Recently, overexpression of the MtrC-MtrD-MtrE efflux pump was shown to be critically involved in the
capacity of gonococci to develop chromosomally mediated resistance to penicillin G, which for over 40 years was
used to treat gonococcal infections. Mutations in either the promoter or the coding sequence of the mtrR gene,
which encodes a repressor of the efflux pump operon, decrease gonococcal susceptibility to penicillin. We now
describe the capacity of MtrR to directly or indirectly influence the expression of two other loci that are
involved in gonococcal susceptibility to penicillin: ponA, which encodes penicillin-binding protein 1 (PBP 1),
and the pilMNOPQ operon, which encodes components of the type IV pilus secretion system, with PilQ acting
as a channel for entry for penicillin. We determined that MtrR increases the expression of ponA directly or
indirectly, resulting in increased levels of PBP 1, while repressing the expression of the divergently transcribed
pilM gene, the first gene in the pilMNOPQ operon. Taken together with other studies, the results presented
herein indicate that transcriptional regulation of gonococcal genes by MtrR is centrally involved in determin-
ing levels of gonococcal susceptibility to penicillin and provides a framework for understanding how resistance
developed over the years.
The strict human pathogen Neisseria gonorrhoeae continues
to be a public health problem due to its frequency of infection
(estimated at over 60 million cases per year), its ability to evade
the immune system, and its increasing resistance to antibiotics
(2). Antibiotic resistance is especially worrisome in underde-
veloped countries, where effective treatment often requires the
use of more expensive drugs that are not always available. The
relatively inexpensive antibiotic penicillin G was used clinically
for over 40 years until 1985, when it became evident that there
was an unacceptably high prevalence of clinically resistant
strains. These strains often did not produce -lactamase (9)
but instead had a number of chromosomal mutations that
affected penicillin entry, target recognition, or efflux (5, 11, 24,
27, 36, 38). The report (10) of one such resistant strain in the
United States prompted the removal of penicillin from the
CDC-recommended treatment regimen.
Mutations in at least five chromosomal genes are required
for high-level chromosomally mediated penicillin resistance in
gonococci. These genes encode mutated forms of penicillin-
binding protein 1 (PBP 1) (27) and PBP 2 (36), the major outer
membrane protein PorBIB (24), the type IV pilus secretin
protein PilQ (44), and the transcriptional repressor MtrR (14,
25), which negatively regulates the expression of the mtrCDE-
encoded efflux pump. Accumulating evidence (25, 38) has re-
vealed the importance of overexpression of the MtrC-MtrD-
MtrE efflux pump, which has the capacity to recognize and
export structurally diverse antimicrobials (14), in gonococcal
penicillin resistance due to mtrR mutations. The 23-kDa MtrR
protein, a member of the TetR family of transcriptional re-
pressors with a helix-turn-helix motif near its N terminus (25),
binds in a specific manner to the mtrCDE promoter (20)
through two homodimers that recognize two pseudo-direct
repeats within the mtrCDE promoter (16). MtrR may have a
more global regulatory property in that it has been shown to
negatively regulate the expression of two additional genes:
mtrF, which encodes an inner membrane accessory protein
required for maximal efflux of antimicrobials by the MtrC-
MtrD-MtrE efflux pump in mtrR mutants (39, 40), and farR,
which encodes the transcriptional repressor of the farAB-en-
coded efflux pump (18, 19). Moreover, earlier work by Dough-
erty et al. (5) suggested that introduction of a then-undefined
mtrR mutation into a penicillin-susceptible recipient strain re-
sulted in a decreased level of penicillin binding to PBP 1
(encoded by ponA) as determined by [3H]penicillin G binding.
Because changes in the expression of the mtrCDE efflux pump
would not be expected to have an effect on [3H]penicillin G
binding to isolated membranes used in the experiments de-
scribed by Dougherty et al. (5), we hypothesized that the mtrR
mutation might modulate the expression of ponA, in addition
to its primary role of regulating the expression of the mtrCDE
efflux pump. Interestingly, ponA is adjacent to, but transcrip-
tionally divergent from, the pilMNOPQ operon. This operon
encodes components of the type IV pilus secretion system (6,
7), and recent studies (3, 44) have implicated the multimeric
PilQ secretin in antibiotic (including penicillin) permeation in
gonococci.
Since mutations in ponA and pilQ are necessary for gono-
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cocci to express high-level chromosomally mediated resistance
to penicillin (27, 32) and such strains also bear mutations in
mtrR, we investigated whether MtrR also regulates these
genes. We now report that MtrR can positively regulate the
expression of ponA while repressing pilMNOPQ transcription
and propose that this DNA-binding protein functions in mod-
ulating gonococcal susceptibility to penicillin by controlling the
expression of multiple genes. (A preliminary account of these
findings was presented at the 15th International Pathogenic
Neisseria Conference [10 to 15 September 2006] in Cairns,
Australia.)
MATERIALS AND METHODS
Bacterial strains and culture conditions. The bacterial strains used in this
study are listed in Table 1. Escherichia coli strain TOP10 (Invitrogen, Carlsbad,
CA) and E. coli DH5 mcr (29) were used in all cloning experiments. E. coli
strains were grown in Luria-Bertani (LB) broth or on LB agar plates at 37°C. N.
gonorrhoeae strain FA19 was used as the primary gonococcal strain (21, 35). N.
gonorrhoeae strains were grown on gonococcal medium base (GCB) agar (Difco
Laboratories, Detroit, MI) containing glucose and iron supplements at 37°C
under 3.8% (vol/vol) CO2 as described previously (30). All chemicals were
purchased from Sigma Biochemical (St. Louis, MO).
Construction of strain FA19 mtrR GC3mtrR. In order to complement the
mtrR deletion in FA19 mtrR, the mtrR gene and promoter region were ampli-
fied by PCR (pGC35mtrR, 5-GGTTAATTAACGCCTTAGAAGCATAAAA
AGC-3; 3mtrR, 5-GGGTTTAAACTTATTTCCGGCGCAGGCAG-3) from
wild-type strain FA19, which produces a functional MtrR repressor (20). The
resulting DNA fragment was inserted into the PmeI and PacI sites of pGCC3
(22) (kindly provided by A. Jerse and H. Seifert) to produce pGC3mtrR, and the
correct orientation and nucleotide sequence were confirmed by DNA sequenc-
ing. pGC3mtrR was digested with ClaI, and the fragment containing the gono-
coccal lctP gene, mtrR, ermC (an erythromycin resistance cassette), and aspC was
purified and used to transform gonococcal strain FA19 mtrR. Transformations
were performed as previously described (12). Transformants were selected on
GCB containing 1 g/ml of erythromycin.
Construction of the ponA-lacZ and pilM-lacZ fusions in gonococci. Transla-
tional lacZ fusions were constructed as previously described (34). In brief, the
promoter sequence of ponA was amplified by PCR from strain FA19 using
primers 5PponA (5-GGGGATCCTTCCAATTGAATTTGGTTTAAACT-3)
and 3PponA (5-GGGGATCCCGAATCATAGCTGAATAATAATTTAC-3).
The promoter sequence of pilM was amplified by PCR from strain FA19 using
primers 5PpilM (5-ATGGATCCAACGGCATTTTAGGCTGGTAA-3) and
3PpilM (5-ATGGATCCCGGCGCATGATGAAAGTTCCTG-3). The result-
ing DNA fragments were inserted into the BamHI site of pLES94 (33), and the
recombinant plasmids were introduced into E. coli DH5 mcr by transformation.
Correct insertion and orientation were confirmed by PCR analysis and DNA
sequencing. The plasmids were used to transform strains FA19, FA19 mtrR,
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Description or relevant genotype Source or reference
Strains
Neisseria gonorrhoeae
FA19 Wild type 13
FA19 mtrR 98% deletion of the coding sequence of mtrR 14
FA19 mtrR GC3mtrR mtrR complemented with a wild-type copy of mtrR inserted into the gonococcal
chromosome (Emr)
This study
FA19 ponA-lacZ Translational fusion of the promoter region of ponA to the lacZ gene and inserted into
the chromosome (Cmr)
This study
FA19 mtrR ponA-lacZ mtrR; translational fusion of the promoter region of ponA to the lacZ gene and inserted




Complemented mtrR; translational fusion of the promoter region of ponA to the lacZ
gene and inserted into the chromosome (Emr) (Cmr)
This study
FA19 pilM-lacZ Translational fusion of the promoter region of pilM to the lacZ gene and inserted into the
chromosome (Cmr)
This study
FA19 mtrR pilM-lacZ mtrR; translational fusion of the promoter region of pilM to the lacZ gene and inserted




Complemented mtrR; translational fusion of the promoter region of pilM to the lacZ
gene and inserted into the chromosome (Emr) (Cmr)
This study
FA19 ponA-lacZ¥ Translational fusion of the promoter region of ponA, containing the 8-bp mutation, to the
lacZ gene and inserted into the chromosome (Cmr)
This study
FA19 mtrR ponA-lacZ¥ mtrR; translational fusion of the ponA promoter region, containing the 8-bp mutation, to
the lacZ gene and inserted into the chromosome (Cmr)
This study
Escherichia coli
DH5 mcr F 80d lacZM15 (lacZYA-argF)U169 endA1 recA1 hsdR17(rK
 mK
) deoR thi-1
supE44 	 gyrA96 relA1
29
TOP10 
F mcrA (mrr-hsdRMS-mcrBC) 80 lacZM15 lacX74 recA1 deoR araD139 (ara-
leu)7697 galU galK rpsL (Strr endA1 nupG)
Invitrogen
Plasmids
pBAD-TOPO-T/A pUC-derived protein expression vector; Apr Invitrogen
pLES94 pUC18-derivative allowing a chromosomal lacZ fusion at the proAB site in Ng (Apr)(Cmr) 33
pPponA pLES94 containing the 300-bp upstream sequence of ponA at the BamHI site This study
pPpilM pLES94 containing the 300-bp upstream sequence of pilM at the BamHI site This study
pPponA¥ pLES94 containing the 300-bp upstream sequence of ponA, containing the
8-bp mutation, at the BamH1 site
This study
pGCC3 pHSS6-derived plasmid for genetic complementation at a secondary site within the N.
gonorrhoeae chromosome (Kmr)(Emr)
22
pGCC3mtrR pGCC3 containing a wild-type copy of mtrR and upstream promoter sequences This study
4570 FOLSTER ET AL. J. BACTERIOL.
and FA19 mtrR GC3mtrR to allow insertion into the chromosomal proAB
locus. Transformants were selected on GCB agar containing 1 g/ml of chlor-
amphenicol.
Preparation of cell extracts and -Gal assays. The strains containing lacZ
translational fusions were grown overnight on GCB agar plates containing 1
g/ml of chloramphenicol. Cells were scraped, washed once with phosphate-
buffered saline (pH 7.4), and resuspended in lysis buffer (0.25 mM Tris, pH 8.0).
Cells were broken by repeated freeze-thaw cycles. The cell debris was removed
by centrifugation at 15,000  g for 8 min at 4°C. -Galactosidase (-Gal) assays
were performed as previously described (34).
EMSAs. Electrophoretic mobility shift assays (EMSAs) using purified MtrR
fused to maltose-binding protein (MBP) were performed as previously described
(20). All probes were amplified by PCR from FA19 chromosomal DNA. In brief,
the intergenic region of ponA-pilM was amplified by PCR using 3PponA and
3PpilM, and the promoter sequence of mtrC was PCR amplified using 5PmtrC
(5-CGTTTCGGGTCGGTTTGACG-3) and 3PmtrC (5-GCTTTGATACCC
GAATGTTCG-3). The overlapping probes used in the MtrR-binding site study
were amplified by PCR using the following primer pairs: 5ponA225 (5-GCAA
CCAGACCCACTCCA-3) and 3ponA75 (5-TTGAAACCGTGCTTTGTAG-
3), 5ponA75 (5-TGTGCAAAGAACAAGGAATCC-3) and 3pilM-75 (5-
ATTGAGTCCCGAAGATTTTTTA-3), 5ponA50 (5-CGGATACCGAAAC
GGTTAC-3) and 3pilM-100 (5-TATCGATGCCGATTGCCGC-3), and
5ponA25 (5-TACAAATAAAGCAGGAACTTTCA-3) and 3pilM-125 (5-A
CCATTTTGATGGAATGCTGG-3). The resulting PCR products were end
labeled with [-32P]dATP using T4 polynucleotide kinase (New England Biolabs,
Beverly, MA). The labeled DNA fragments (10 ng) were incubated with purified
MBP-MtrR in 30 l of reaction buffer [10 nM Tris-HCl (pH 7.5), 0.5 mM
dithiothreitol, 0.5 EDTA, 4% (vol/vol) glycerol, 1 mM MgCl2, 50 mM NaCl,
poly(dI-dC) (0.5 g/ml), salmon sperm (200 ng/ml)] at 4°C for 20 min. Samples
were subjected to electrophoresis on a 6% (wt/vol) polyacrylamide gel at 4°C,
followed by autoradiography. Densitometry was performed using Scion Image (v.
alpha 4.0.3.2; Frederick, MD).
Mutagenesis of the MtrR-binding site. PCR mutagenesis was performed using
the overlapping primers 5mutMBS (5-CGGTTACTCAAGTGCACCATAAA
GCAGG-3) and 3mutMBS (5-CCTGCTTTATGGTGCACTTGAGTAACC
G-3), each containing the 8-bp transversion mutation of the MtrR-binding site.
First, two fragments were amplified by PCR from FA19 chromosomal DNA
using the primer sets 3PponA/3mutMBS and 3PpilM/5mutMBS. The resultant
fragments were gel purified using a QIAquick purification kit (QIAGEN Inc.,
Valencia, CA), and these fragments then served as both primers and templates
for a second PCR. After 8 reaction cycles, primers 3PponA and 3PponA were
added to the PCR and amplification continued for an additional 25 cycles. The
resulting DNA fragment containing the mutation was purified and served as the
template for the last PCR, using primers 5PponA and 3PponA. The resulting
DNA fragment was inserted into the BamHI site of pLES94, resulting in the
ponA-lacZ¥ construct. The recombinant plasmid was introduced into DH5 mcr
by transformation. Correct insertion and orientation were confirmed by PCR
analysis, and DNA sequencing analysis confirmed the mutation of the MtrR-
binding site. The plasmid was used to transform strains FA19 and FA19 mtrR
to allow insertion into the chromosomal proAB gene. Transformants were se-
lected on GCB agar containing 1 g/ml of chloramphenicol.
Western blotting of PBP 1. Western blotting of PBP 1 was done essentially as
described previously (28). Briefly, cultures of FA19, FA19 mtrR, and FA19
mtrR GC3mtrR were grown overnight on GC plates, and cells were swabbed
into GC broth containing 10 mM MgCl2 and diluted to an 0.18 optical density at
600 nm. One-milliliter aliquots of each sample were pelleted, the cell pellets were
dissolved in 100 l of 1 sodium dodecyl sulfate (SDS)-polyacrylamide gel
electrophoresis buffer and boiled, and aliquots were separated on an 8% poly-
acrylamide-SDS gel. Alternatively, the cells were lysed, the particulate fractions
were isolated, and equal levels of protein were electrophoresed as described
above. The proteins were transferred to polyvinylidene difluoride membranes in
10 mM CAPS [3-(cyclohexylamino)-1-propanesulfonic acid], pH 11, 5% metha-
nol, 0.005% SDS for 4 h at 200 mA on a semidry blotting apparatus (Owl
Scientific, Portsmouth, NH). The blot was incubated with a 1/5,000 dilution of
rabbit PBP 1 antisera (28) followed by horseradish peroxidase-conjugated goat
anti-rabbit antibody, and the protein bands were visualized with Pierce Super-
Signal West Pico chemiluminescence reagent (Rockford, IL). Films were imaged
on a Bio-Rad Fluor-S system and quantified with Bio-Rad QuantityOne software
(Bio-Rad, Hercules, CA).
RESULTS
We examined the capacity of MtrR to regulate the expres-
sion of the ponA-pilMNOPQ locus (Fig. 1) in the gonococcal
chromosome to determine if this DNA-binding protein can
control the expression of proteins involved in penicillin resis-
tance in addition to the mtrCDE-encoded efflux pump. We
chose to analyze this region of the gonococcal chromosome
because levels of PBP 1 may be affected by mtrR mutations (5),
the multimeric PilQ has been implicated in penicillin perme-
ation, and a mutation in pilQ (pilQ2, previously termed penC)
is necessary for high-level chromosomally mediated penicillin
resistance in stepwise transformants of FA19 (27).
Expression of ponA is activated by MtrR. To monitor the
regulation of ponA expression by MtrR, a translational re-
porter fusion system was employed. For this purpose, a ponA
promoter-lacZ fusion was constructed and transformed into
the isogenic strains FA19 and FA19 mtrR, which resulted in
a single copy of the ponA promoter fused translationally to
lacZ within the proAB chromosomal locus. -Gal activity in cell
lysates from these strains indicated that the expression of ponA
decreased about twofold in strain FA19 mtrR strain com-
pared to that in its otherwise isogenic wild-type parental strain,
FA19 (Fig. 2A). To confirm that these results were due to
deletion of mtrR and not to a polar effect, FA19 mtrR
ponA-lacZ was complemented with the wild-type mtrR gene
from strain FA19, which was inserted at a secondary site within
the gonococcal chromosome (between the lctP and aspC
genes) to create FA19 mtrR GC3mtrR ponA-lacZ (22). Using
FIG. 1. (A) Genetic organization of the divergently transcribed ponA and pilMNOPQ genes. (B) DNA sequence of the 150-bp intergenic region.
Repeat I (upper strand) and repeat II (lower strand, opposite direction) are shown underlined and bolded, indicating the location of the
MtrR-binding site.
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FIG. 2. (A) Regulation of ponA expression by MtrR. Shown are the -Gal activities per mg of total protein in cell extracts of reporter strains
FA19 ponA-lacZ, FA19 mtrR ponA-lacZ, and FA19 mtrR GC3mtrR ponA-lacZ. The figure represents one experiment of three replicates; each
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this strain, we found that complementation of FA19 mtrR
ponA-lacZ with the mtrR gene restored ponA expression to a
level similar but slightly higher than that observed in FA19
ponA-lacZ (Fig. 2A).
Based on these results, we next examined whether protein
levels of PBP 1 were decreased due to the mtrR deletion
mutation. Accordingly, total membrane fractions were pre-
pared from strains FA19, FA19 mtrR, and FA19 mtrR
GC3mtrR, and PBP 1 levels were determined by Western blot-
ting using rabbit anti-PBP 1 antisera (28) (Fig. 2B). Densitom-
etry was performed to determine the ratio of PBP 1 levels in
FA19 relative to those in FA19 mtrR and FA19 mtrR
GC3mtrR. These values were then plotted on the same graph
as the gene expression (-Gal activity) data, with the densi-
tometry levels adjusted such that the value observed in FA19
was equal to that determined for gene expression in strain
FA19 (Fig. 2C). These data show that PBP 1 levels were de-
creased in strain FA19 mtrR to nearly the same extent as that
determined in the gene expression assay and recovered to
wild-type levels in the complemented strain FA19 mtrR
GC3mtrR. This experiment was repeated two other times with
whole-cell lysates of the three strains, and results similar to
those with membranes were obtained (data not shown). Taken
together, these results suggested that MtrR directly or indi-
rectly stimulates ponA expression, resulting in increased levels
of PBP 1.
Expression of pilM is repressed by MtrR. pilM is the first
gene in the gonococcal pilMNOPQ operon (Fig. 1), and tran-
scription of this operon, including pilQ, appears to be driven by
a promoter upstream of pilM. The ponA-pilM intergenic region
is only 150 bp, and the predicted 10 and 35 consensus sites
for these loci appear to overlap. Based on this gene organiza-
tion, we tested whether MtrR regulates pilM expression as was
observed for the divergently transcribed ponA gene. For this
purpose, a pilM promoter-lacZ fusion was constructed and
transformed into FA19, FA19 mtrR, and FA19 mtrR
GC3mtrR, which resulted in a single copy of the promoter of
pilM fused translationally to lacZ within the proAB locus of the
gonococcal chromosome. Expression of pilM increased greater
than twofold in strain FA19 mtrR versus that in the parental
strain, FA19, indicating that MtrR represses the expression of
pilM (Fig. 3). Complementation of mtrR in strain FA19 mtrR
GC3mtrR restored the repression of pilM to wild-type levels.
MtrR directly binds to the ponA-pilM promoter region. Be-
cause MtrR appeared to increase ponA expression (Fig. 2A)
while repressing pilM expression (Fig. 3), we examined whether
replicate was performed in triplicate. Error bars represent 1 standard deviation. The differences between strains FA19 ponA-lacZ and FA19 mtrR
ponA-lacZ as well as between strains FA19 mtrR ponA-lacZ and FA19 mtrR GC3mtrR ponA-lacZ were significant (P  0.0001). (B) Total
membranes from strains FA19, FA19 mtrR, and FA19 mtrR GC3mtrR were prepared, and PBP 1 levels were determined by Western blotting
using rabbit anti-PBP 1 antisera. Equal amounts of protein (3 g) were loaded in each lane. Western blotting of whole-cell lysates from these same
strains gave similar results (data not presented). (C) Comparison of the MtrR-dependent regulation of ponA gene expression and PBP 1 protein
levels determined by densitometry. Densitometry was performed to determine the relative ratios of PBP 1 in strains FA19, FA19 mtrR, and FA19
mtrR GC3mtrR. These values were plotted on the same graph as that shown in panel A, with the densitometry levels for FA19 PBP 1 set to the
same values as the -Gal activity levels for FA19 ponA-lacZ for purposes of comparison. Light gray bars represent gene expression, while dark gray
bars represent protein levels.
FIG. 3. Regulation of pilM expression by MtrR. -Gal activities per mg of total protein in cell extracts of reporter strains FA19 pilM-lacZ, FA19
mtrR pilM-lacZ, and FA19 mtrR GC3mtrR pilM-lacZ are shown. The figure represents one experiment of three replicates; each replicate was
performed in triplicate. Error bars represent 1 standard deviation. The P value (Student’s t test) between strains FA19 pilM-lacZ and FA19 mtrR
pilM-lacZ was 0.0024, and that between strains FA19 mtrR pilM-lacZ and FA19 mtrR GC3mtrR pilM-lacZ was 0.0017.
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MtrR could bind in a specific manner to the ponA-pilM pro-
moter region. MtrR has been shown previously to bind specif-
ically to the mtrR-mtrC intervening region (20), and this in-
teraction served as a positive control in the DNA-binding
experiments described below. Initial DNA-binding experi-
ments using EMSA showed that MtrR bound to both the
mtrR-mtrC and the ponA-pilM promoter regions in a concen-
tration-dependent manner (data not shown). To verify the
specificity of this interaction, a competitive EMSA was per-
formed using specific unlabeled PCR-derived probes from the
ponA-pilM and mtrR-mtrC promoter regions and a nonspecific
probe derived from an internal region of the mtrC gene. We
observed that increasing amounts of the unlabeled ponA-pilM
probe competed with MtrR binding to the labeled ponA-pilM
region (Fig. 4), whereas the unlabeled, nonspecific probe was
nearly fivefold less inhibitory, as determined by densitometric
analysis. It is important to note that whereas 100 unlabeled
ponA-pilM promoter probe decreased MtrR binding to the
labeled ponA-pilM probe, 100 unlabeled mtrR-mtrC pro-
moter probe completely abolished MtrR binding, suggesting
that MtrR binds to the mtrC-mtrR promoter region with much
higher affinity than to the ponA-pilM promoter region.
Identification of the MtrR-binding site. The results from the
EMSA experiments suggested that MtrR has the capacity to
bind within the ponA-pilM intergenic region. Therefore, we
sought to identify the location of the MtrR-binding site within
this 150-bp region. Initial attempts to do this by DNase I
footprinting gave inconsistent results (data not presented),
perhaps due to the lower affinity of MtrR for this site than for
the mtrCDE promoter region. Accordingly, a series of 150-bp
overlapping probes (Fig. 5) were used in EMSAs to delimit the
region required for MtrR binding. In the absence of MtrR,
each labeled probe migrated as two bands, likely due to dif-
ferences in the secondary structure of the DNA; the migration
position of the MtrR-DNA complexes is designated by the
arrow in Fig. 5. MtrR failed to bind to the probe (from bp 225
to bp 75) encompassing part of the ponA coding sequence and
the first 75 bp of the intergenic region (Fig. 5). However, MtrR
did bind to the probe (from bp 75 to bp 75) encompassing the
last 75 bp of the intergenic region and part of pilM, suggesting
that the MtrR-binding site is located within the last 75 bp of
the ponA-pilM intergenic region. Within this 75-bp fragment,
MtrR bound to the probe from bp 50 to bp 100 but was
unable to bind to the probe from bp 25 to bp 125. Taken
together, these results suggested that a 25-bp region located
between 50 and 25 bp upstream of the pilM start codon con-
tains either part of or the entire MtrR-binding site.
MtrR binds to the mtrR-mtrC intergenic region (20), and a
15-bp binding site containing two pseudo-direct repeats (un-
derlined; 5-CCGTGCAATCGTGTA-3) was recently shown
to be necessary and sufficient for MtrR binding within the
mtrCDE promoter (16). Based on homology to these repeats, a
possible MtrR-binding site containing two pseudorepeats within
the required 25-bp sequence of the ponA-pilM region was iden-
tified (5-TTGTACA-3 and 5-CTGTACA-3 [bold, underlined
sequences in Fig. 1]). One of these repeats overlapped the
putative 10 promoter hexamer sequence used for transcrip-
tion of ponA that was previously predicted by Ropp and
Nicholas (28). To determine if these repeats were required for
MtrR binding, pseudorepeat I was mutated from 5-TTGTAC
A-3 to 5-GGTGCAC-3 and pseudorepeat II was mutated from
5-CTGTACA-3 to 5-AGTGCAC-3. The impact of these mu-
tations on MtrR binding to the intergenic region was then deter-
FIG. 4. Competitive EMSA using purified MBP-MtrR fusion pro-
tein. The radiolabeled probe migrating at the bottom of the gel is the
150-bp intergenic region of ponA-pilM. SP, specific cold probe (ponA-
pilM intergenic region); NSP, nonspecific cold probe (internal region
of mtrC); PC, positive-control cold probe (mtrR-mtrC intergenic re-
gion). The lane without MtrR is designated by 0 and shows the elec-
trophoretic migration of the labeled probe alone. The arrow indicates
the protein/DNA complex. At a 100-fold level of unlabeled probe, SP
was nearly 5-fold more effective than the NSP in competing with the
labeled probe for MtrR-binding.
FIG. 5. EMSAs performed on the 150-bp overlapping radiola-
beled probes within the ponA-pilM intergenic region using purified
MBP-MtrR protein. The diagram at top indicates the location of
each probe. Increasing amounts (0, 2, 4, and 8 g) of MBP-MtrR
protein were added to each binding reaction. The lane without
MtrR is designated by 0 and shows the electrophoretic migration of
the labeled probes alone. The arrow indicates the protein/DNA
complex.
4574 FOLSTER ET AL. J. BACTERIOL.
mined by EMSA. As opposed to its binding to the wild-type target
DNA (Fig. 6), MtrR failed to bind the mutated target DNA,
indicating that at least one (and likely both) of these two sites is
required for its binding to the transcriptional regulator.
An MtrR-binding site mutation deregulates ponA expres-
sion. Since mutation of the MtrR-binding site resulted in the
inability of MtrR to bind to the ponA-pilM intergenic region,
we next tested whether these mutations would prevent MtrR-
dependent regulation of these genes. The above-mentioned
mutations were introduced into the pPponA-lacZ plasmid, re-
sulting in plasmid construct pPponA-lacZ¥. This construct was
then transformed into strains FA19 and FA19 mtrR, and
ponA expression was assessed by quantifying -Gal activity. As
previously observed, the expression of ponA from the wild-type
promoter was decreased in FA19 mtrR compared to that in
its parental strain, FA19 (Fig. 7). However, there was no sig-
nificant difference in ponA expression observed in the FA19
ponA-lacZ¥ and FA19 mtrR ponA-lacZ¥ strains, with the
ponA promoter containing the mutation (Fig. 7). Therefore,
mutation of the MtrR-binding site within the ponA promoter
results in the loss of MtrR-dependent regulation of ponA.
Interestingly, the mutation of the MtrR-binding site should
have also disrupted the predicted 10 region of the ponA
promoter. However, our data clearly demonstrate that ponA
expression was not abolished by this mutation, as expression in
both FA19 ponA-lacZ¥ and FA19 mtrR ponA-lacZ¥ was at
least as great as that observed for FA19 mtrR ponA-lacZ (Fig.
7), suggesting that this was not the location of the 10 region.
Taken together, these results are consistent with MtrR serving
as an enhancer of ponA expression.
DISCUSSION
The loss of penicillin as an effective antibiotic in the treat-
ment of gonorrhea resulted not from the acquisition of the
-lactamase plasmid (still rarely found in gonococci) that was
reported in the 1970s (9) but rather from the sequential accu-
mulation over a 40-year time period of mutations in the mtrR,
porB1B, and ponA genes as well as the creation and horizontal
transfer of mosaic penA genes (24, 27, 36, 44). Each of these
FIG. 6. EMSA performed on a wild-type or mutated ponA-pilM pro-
moter region using purified MBP-MtrR protein. Probe ponA-pilM con-
tains the wild-type MtrR-binding site, while the ponA-pilM¥ probe con-
tains the mutated MtrR-binding site. Increasing amounts (0, 2, 4, and 8
g) of MBP-MtrR protein were added to each binding reaction. The lane
without MtrR is designated by 0 and shows the electrophoretic migration of
the labeled probes alone. The arrow indicates the protein/DNA complex.
FIG. 7. Mutation of the MtrR-binding sites within the ponA-pilMNOPQ intergenic region disrupts MtrR-dependent regulation of ponA
expression. Shown are the -Gal activities per mg of total protein in cell extracts of reporter strains FA19 ponA-lacZ, FA19 mtrR ponA-lacZ,
FA19 ponA-lacZ¥, and FA19 mtrR ponA-lacZ¥. The figure represents one experiment of three replicates; each replicate was performed in
triplicate. Error bars represent 1 standard deviation. The P value (Student’s t test) between strains FA19 ponA-lacZ and FA19 mtrR ponA-lacZ
was 0.0001. The difference in activity determined for FA19 ponA-lacZ¥ and FA19 mtrR ponA-lacZ¥ was not significant.
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resistance determinants, which are transferred from a resistant
strain to a susceptible strain in a specific order (27, 36, 40, 44),
incrementally increases in resistance until treatment failure
occurs (MIC  2 g/ml). Mutations in ponA and penA de-
crease penicillin susceptibility in gonococci by decreasing the
rate of penicillin acylation of PBPs 1 and 2, respectively, while
mtrR mutations result in overexpression of the MtrC-MtrD-
MtrE efflux pump. Although overexpression of the efflux pump
on its own results in only a small increase in resistance to
penicillin, mtrR mutations are required for gonococci to exhibit
high-level chromosomally mediated resistance to penicillin (25,
38). The penB resistance determinant, which encodes PorBIB
variants with multiple amino acid changes in the putative loop
3 constriction loop, was originally thought to reduce antibiotic
entry by altering permeation of antibiotics through the porin
channel, but this has recently been brought into question (17).
Finally, recent evidence indicates that mutations in pilQ also
affect antibiotic entry into gonococci (3).
Because of the ability of MtrR to control the expression of
mtrCDE (14) and the impact of mtrR mutations on pump levels
and penicillin resistance (38), we asked if this DNA-binding
protein might also regulate other genes important for penicil-
lin resistance. The evidence presented herein strongly suggests
that the transcriptionally divergent ponA-pilMNOPQ gene
cluster is subject to MtrR transcriptional control. Specifically,
ponA expression appears to be increased in the presence of
MtrR while pilMNOPQ expression is subject to MtrR repres-
sion at a level similar to that observed for mtrCDE (14, 15).
EMSA and mutagenesis studies strongly suggest that the pseu-
dorepeats TTGTACA and CTGTACA, located within the
ponA-pilM intergenic region, form the MtrR-binding site. In-
terestingly, these sites are on opposite strands of the DNA, a
feature not previously observed for the TetR family of tran-
scriptional regulators but perhaps necessary for control of
the divergently transcribed ponA-pilMNOPQ region.
Increasing evidence indicates that MtrR plays a central role
in modulating levels of gonococcal susceptibility to antimicro-
bial agents (15), and there is strong evidence to suggest that it
performs this function primarily by modulating levels of the
MtrC-MtrD-MtrE efflux pump. We have also determined that
MtrR regulates the expression of mtrF (11), which encodes a
cytoplasmic membrane protein needed for high-level hemag-
glutinin resistance mediated by the MtrC-MtrD-MtrE pump,
as well as farR, which encodes the transcriptional repressor of
the farAB-encoded efflux pump that exports long-chain fatty
acids (18). The results presented herein implicate MtrR as a
regulator of ponA and pilMNOPQ expression and lend further
support to the notion that MtrR has more global regulatory
properties than previously appreciated (15, 37). A recurring
theme of the MtrR-regulated genes identified thus far is that
all appear to be involved in resistance to host-derived antimi-
crobials or classical antibiotics. With respect to PilQ, a point
mutation in pilQ (pilQ1) was previously shown to result in the
decreased resistance of gonococci to a number of antimi-
crobials through a change in the structure of the PilQ outer
membrane pore that enhanced the entry of antimicrobials (3).
A second pilQ point mutation, termed penC (pilQ2) (44), ap-
peared to cause a defect in PilQ multimerization and a subse-
quent loss of antibiotic entry. Moreover, this mutation was
found to be essential for the phenotypic expression of high-
level penicillin resistance in laboratory transformation experi-
ments. Interestingly, the increase in resistance due to pilQ2 was
observed only in strains containing the penA, mtrR, and penB
resistance determinants, and together with ponA, these five
determinants were capable of conferring high-level penicillin
resistance to the same level as that found in clinical isolates.
In contrast to that of other MtrR-regulated genes, ponA
gene expression appears to be transcriptionally enhanced by
MtrR, a finding that was somewhat surprising as members of
the TetR family are usually repressors. However, one other
TetR member, DhaS from Lactococcus lacti, has been shown
to be an activator of gene expression (4). While the physiolog-
ical relevance of mtrCDE regulation by MtrR and the impact
of mtrR mutations in gonococci have been documented (38),
the benefit of ponA and pilMNOPQ regulation by this tran-
scriptional regulator is less clear. At first glance, it would seem
to be disadvantageous in vivo for gonococci to differentially
regulate ponA and pilMNOPQ, as such changes in gene expres-
sion that occur in mtrR mutants would be expected to increase
antibiotic uptake due to increased expression of pilQ and de-
crease peptidoglycan structure or bacterial growth rate due to
decreased expression of ponA. However, since the type IV
pilus has been shown to be required for motility, DNA uptake,
virulence, and biofilm formation (26, 37, 41, 42), increased
expression of the pilus apparatus genes may give gonococci
with mtrR mutations a survival advantage, along with increased
MtrC-MtrD-MtrE pump levels, during host infections. We
propose that MtrR activation of ponA either directly or indi-
rectly provides gonococci a mechanism to resist the lethal
action of the host environment, perhaps due to changes in
peptidoglycan structure, which makes the gonococci less sus-
ceptible to damaging agents. In Neisseria meningitidis, alter-
ations in PBP 2 have been shown to result in compositional
modifications in peptidoglycan structure (1). Thus, host anti-
microbials that damage the cell envelope integrity may have
reduced activities against mtrR mutants, which were shown
previously (13) to have altered peptidoglycan cross-linking and
lytic behavior. More-in-depth interpretations of the biological
significance of the data presented herein will require addi-
tional experimentation. However, in support of our hypothesis
that these changes in gene expression are not disadvantageous
in vivo are reports that gonococci with mtrR mutations are
often isolated from patients with rectal or urogenital infections
(8, 23, 31, 43). Moreover, recent experiments showed that
mutations in mtrR can enhance gonococcal fitness in a murine
vaginal infection model (D. M. Warner, J. P. Folster, W. M.
Shafer, and A. Jerse, unpublished results). Hence, we propose
that under certain circumstances and infections, MtrR regula-
tion of gene expression is an important determinant of gono-
coccal survival in vivo. A thorough understanding of the MtrR
regulon in gonococci should therefore provide important in-
sights regarding antibiotic resistance and pathogenesis as well
as the link between these two phenotypes.
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